MedTrace Logo

INtervention Study In overweiGHT Patients With COPD

NCT02634268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 684

Last updated 2022-04-07

Study results available
· View outcomes & findings →

Summary

Symptoms of chronic obstructive pulmonary disease (COPD) and high body mass index (BMI) overlap. The investigators are trying to find out if a program proven to help people lose a modest amount of weight and increase their physical activity will improve COPD symptoms for those with a high BMI. The program uses a series of video sessions and self-study handouts focused on healthy eating and increasing physical activity, and encourages participants to monitor their weight, diet, and physical activity for one year. For those who want to, they will be able to work with a health coach to help meet weight and activity goals. We hope that the program will lead to improved exercise tolerance, body weight, dyspnea, generic health-related quality of life, and major cardiovascular risk factors (central obesity by waist circumference, Framingham Risk Score, and blood pressure) through 12 months of follow-up. To be in the study, participants will need to have COPD, high BMI, history of smoking, shortness of breath, and be at least 40 years old.

Conditions

Interventions

BEHAVIORAL

Lifestyle Intervention

Behavioral lifestyle intervention focused on healthy eating and physical activity

Sponsors & Collaborators

  • VA Puget Sound Health Care System

    collaborator FED

  • University of Illinois at Chicago

    collaborator OTHER

  • Seattle Institute for Biomedical and Clinical Research

    lead OTHER

Principal Investigators

  • David H Au, MD, MS · VA Puget Sound Health Care System

  • Jun Ma, MD, PhD · University of Illinois at Chicago - Institute for Health Research and Policy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-12
Primary Completion
2020-10-30
Completion
2020-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02634268 on ClinicalTrials.gov